Randomized, placebo-controlled single-ascending-dose study to evaluate the safety, tolerability and pharmacokinetics of the HIV nucleoside reverse transcriptase inhibitor, BMS-986001, in healthy subjects

Transcriptase Inhibitor ◽

Dose Study ◽

Reverse Transcriptase Inhibitor ◽

Single Ascending Dose Study

Safety, tolerability and pharmacokinetics of doravirine, a novel HIV non-nucleoside reverse transcriptase inhibitor, after single and multiple doses in healthy subjects

Antiviral Therapy ◽

10.3851/imp2920 ◽

2014 ◽

Vol 20 (4) ◽

pp. 397-405 ◽

Cited By ~ 41

Author(s):

Matt S Anderson ◽

Jocelyn Gilmartin ◽

Caroline Cilissen ◽

Inge De Lepeleire ◽

Luc van Bortel ◽

...

Keyword(s):

Reverse Transcriptase ◽

Healthy Subjects ◽

Transcriptase Inhibitor ◽

Single And Multiple Doses ◽

Multiple Doses ◽

Evaluation of steady-state pharmacokinetic interactions between ritonavir-boosted BILR 355, a non-nucleoside reverse transcriptase inhibitor, and lamivudine/zidovudine in healthy subjects

Journal of Clinical Pharmacy and Therapeutics ◽

10.1111/j.1365-2710.2010.01235.x ◽

2010 ◽

Vol 37 (1) ◽

pp. 81-88 ◽

Cited By ~ 2

Author(s):

F. Huang ◽

L. Allen ◽

D. B. Huang ◽

F. Moy ◽

R. Vinisko ◽

...

Keyword(s):

Steady State ◽

Reverse Transcriptase ◽

Healthy Subjects ◽

Transcriptase Inhibitor ◽

Pharmacokinetic Interactions ◽

Faculty Opinions recommendation of Detection of low-level K65R variants in nucleoside reverse transcriptase inhibitor-naive chronic and acute HIV-1 subtype C infections.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.12019956.13157054 ◽

2011 ◽

Author(s):

Mark Wainberg ◽

Dimitrios Coutsinos

Keyword(s):

Reverse Transcriptase ◽

Transcriptase Inhibitor ◽

Subtype C ◽

Low Level ◽

Acute Hiv ◽

Reverse Transcriptase Inhibitor ◽

Hiv 1

A Nanoparticle-Encapsulated Non-Nucleoside Reverse-Transcriptase Inhibitor with Enhanced Anti-HIV-1 Activity and Prolonged Circulation Time in Plasma

Current Pharmaceutical Design ◽

10.2174/1381612820666141014125213 ◽

2014 ◽

Vol 21 (7) ◽

pp. 925-935 ◽

Cited By ~ 11

Author(s):

Wen Li ◽

Qian Wang ◽

Yuan Li ◽

Fei Yu ◽

Qi Liu ◽

...

Keyword(s):

Reverse Transcriptase ◽

Transcriptase Inhibitor ◽

Circulation Time ◽

Reverse Transcriptase Inhibitor ◽

Anti Hiv ◽

Hiv 1

Erratum to: Non-nucleoside reverse transcriptase inhibitor efavirenz activates PXR to induce hypercholesterolemia and hepatic steatosis [J Hepatol (2019); 70 (5): 930–940]

Journal of Hepatology ◽

10.1016/j.jhep.2021.01.003 ◽

2021 ◽

Author(s):

Taesik Gwag ◽

Zhaojie Meng ◽

Yipeng Sui ◽

Robert N. Helsley ◽

Se-Hyung Park ◽

...

Keyword(s):

Reverse Transcriptase ◽

Hepatic Steatosis ◽

Transcriptase Inhibitor ◽

Viral load outcome of non-nucleoside reverse transcriptase inhibitor regimens for 2203 mainly antiretroviral-experienced patients

AIDS ◽

10.1097/00002030-200112070-00006 ◽

2001 ◽

Vol 15 (18) ◽

pp. 2385-2395 ◽

Cited By ~ 46

Author(s):

Andrew N. Phillips ◽

Christian Pradier ◽

Adriano Lazzarin ◽

Bonaventura Clotet ◽

Frank-Detlef Goebel ◽

...

Keyword(s):

Viral Load ◽

Reverse Transcriptase ◽

Transcriptase Inhibitor ◽

A novel potent non-nucleoside reverse transcriptase inhibitor acylthiocarbamate derivative with extensive intramolecular π–π interactions

Acta Crystallographica Section C Crystal Structure Communications ◽

10.1107/s0108270106013175 ◽

2006 ◽

Vol 62 (6) ◽

pp. o315-o317 ◽

Cited By ~ 1

Author(s):

Angelo Mugnoli ◽

Alberto Borassi ◽

Andrea Spallarossa ◽

Sara Cesarini

Keyword(s):

Reverse Transcriptase ◽

Transcriptase Inhibitor ◽

Π Interactions ◽

Apricitabine: A Nucleoside Reverse Transcriptase Inhibitor for HIV Infection

Annals of Pharmacotherapy ◽

10.1345/aph.1m160 ◽

2009 ◽

Vol 43 (10) ◽

pp. 1676-1683 ◽

Cited By ~ 2

Author(s):

Monica M Gaffney ◽

Paul P Belliveau ◽

Linda M Spooner

Keyword(s):

Hiv Infection ◽

Reverse Transcriptase ◽

Transcriptase Inhibitor ◽

ChemInform Abstract: Efavirenz: A Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI), and a Previous Structurally Related Development Candidate

ChemInform ◽

10.1002/chin.201151237 ◽

2011 ◽

Vol 42 (51) ◽

pp. no-no

Author(s):

Nobuyoshi Yasuda ◽

Lushi Tan

Keyword(s):

Reverse Transcriptase ◽

Transcriptase Inhibitor ◽

Related Development ◽

Synthesis of a non-nucleoside reverse transcriptase inhibitor in the alkenyldiarylmethane (ADAM) series with optimized potency and therapeutic index

Bioorganic & Medicinal Chemistry Letters ◽

10.1016/s0960-894x(97)10214-1 ◽

1998 ◽

Vol 8 (2) ◽

pp. 195-198 ◽

Cited By ~ 14

Author(s):

Mark Cushman ◽

Agustin Casimiro-Garcia ◽

Karen Williamson ◽

William G. Rice

Keyword(s):

Reverse Transcriptase ◽

Therapeutic Index ◽

Transcriptase Inhibitor ◽